Cancer breakthrough: 100% response rate in CAR-T therapy for multiple myelomaShared by:
Doctors have reported unprecedented success from a new cell and gene therapy for multiple myeloma. The study however is early and small ̶ 35 people ̶ but all patients responded and all except two were in some level of remission within two months. Experts say it is a first for multiple myeloma and rare for any cancer treatment to have such success.
14 Jun 2017 - General